April 2012 Volume 8, Issue 4
Volume 8, Issue 4 | April 2012
April 2012
In this Issue
Research & Development
Pharma pink-slippers find pot of gold
Six years after founding company for downsized R&D scientists, Boston Biomedical is acquired by Japanese pharma DSP for $2.63 billionBeing flexible with Fleximer
Mersana, Endo collaborate on antibody-drug conjugate developmentHeavy ADME
Concert Pharmaceuticals will partner with Avanir Pharmaceuticals to develop and commercialize deuterium-modified dextromethorphan for nervous system disordersJoined together by JNK
Scripps Institute and OPKO Health announce deal for promising Parkinson’s therapyCrossing the 'Valley of Death'
The Wistar Institute and the Moulder Center join forces to accelerate drug developmentUniversity of Pittsburgh and UPMC partner with J&J corporate office
The University of Pittsburgh and UPMC have entered into a partnership with Johnson & Johnson Corporate Office of Science and Technology (COSAT) to support translational researchGlobal News
A new sun rises for vaccines
GSK, Daiichi Sankyo announce Japanese joint ventureHot target for HCV
Enanta Pharmaceuticals, Novartis collaborate on hepatitis C virus drug in deal worth up to $440 millionJumping on JAK1
Abbott and Galapagos collaborate on novel oral therapy for autoimmune diseasesAntibody potential a 'SIMPLE' fact
Human monoclonal antibodies focus of new Shire, arGEN-X allianceComing into the light
Lonza signs Light Path discovery agreement with LegoChem to provide preclinical material of novel therapeutic compoundOmics & Systems Biology
Bridge over the Charles River
The Bridge Project, a landmark cancer research initiative, pairs Koch Institute, Dana-Farber/Harvard Cancer CenterAcquiring a peer across the Atlantic
Abcam to buy San Francisco-based antibody business Epitomics with even mix of cash and sharesSanofi cultivates 'research ecosystem'
Pharma partners with Spain’s Centre for Genomic Regulation to explore potential of translational medicineDelivering genomics to routine care
Foundation Medicine announces collaboration with Array BioPharma to help better target patients for certain cancer treatmentsReady and aiming
RNAi therapeutics get new boost from Arrowhead Research and Axolabs strategic allianceMJFF showcases Parkinson’s disease advances by Kinemed
KineMed Inc. recently announced that it has been awarded funding by the Michael J. Fox Foundation (MJFF) Industry Partnering ProgramContract Services
BGI on board with ‘Novo Nordisk Way’
Denmark’s Novo Nordisk and China’s BGI establish global collaboration framework to accelerate growthMaking genomic research whole
Mayo Clinic taps Complete Genomics to provide outsources whole-genome sequencingCharles River rolls toward improved viral clearance studies
CRO licenses EMD Millipore technology to improve drug product safetyAn immunological decision
Selventa, Janssen form research agreement targeted toward treating immunological diseaseSister companies trod biosimilar path
Celerion and Ricerca Biosciences form the Biosimilars Alliance to provide clients a more effective development path for biosimilarsCommentary
Completing the picture with regulatory information management
Pharmaceutical companies depend on data to bring products to market, but companies struggle to cohesively and coherently manage all that data and all that information.Taking inventory of life-science headcounts
Survival requires innovating again and again at a greater and greater speed. Customers create jobs. No one else can.Editor's Focus
The little biotech that could
Dr. Chiang Li is not the kind of guy you’d expect to be living on a minimum-wage salary. The Harvard Medical School graduate with more than 60 inventions to his name and founder of Boston Biomedical Inc. chose to subsist on a meager salary for the last six years. Why? Read on for his remarkable story of innovation and sacrifice.Diagnostics
Abbott and Merck go FISH
Companies collaborate to develop FISH-based companion diagnostic test for cancer therapyTranslating a pilot into a full collaboration
Molecular Response and OncoMed sign collaboration deal that expands existing relationship in translational oncologyGetting an Angle on cancer
Parsortix signs research agreement with Paterson InstituteReinforcing their lines
Illumina stands fast as Roche continues takeover attemptSpecial Reports
Everything old is new again
Drug repositioning provides cost savings, shortcutsFeature
Great minds think alike
Experimental Bio show brings together numerous specialty societies to advance knowledge in drug discovery, development and moreTools & Technology
A biopharmaceutical bonanza
GE Healthcare acquires Xcellerex as it looks to broaden capabilities in growing biopharmaceutical market and provide start-to-finish offeringsAcross all domains
Certara acquires Simcyp, boosting preclinical research capabilitiesA rock-solid partnership
Rockland, NCI collaboration announces release of new antibodiesComparing apples to Apples
IO Informatics and Sage-N Research announce partnership to discover potential biomarkers, disease causes and preventionTIBCO, ChemAxon integrate analytics data management applications
TIBCO Software Inc. and ChemAxon, providers of chemical software development platforms and desktop applications for the biotechnology and pharmaceutical industries, announced in February the full integration of the TIBCO Spotfire Analytics Platform with ChemAxon’s Instant JChem data management application
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Thermo Scientific™ Centrifuges with GreenCool Technology
Next-generation natural refrigerant cooling system for centrifuges, offering a lower Global Warming Potential and reduced energy consumption.
The crucial role of sample preparation in biotherapy manufacturing
Discover how better sample preparation can unlock improved assay accuracy and analytical results.
Discovering deeper insights into malaria research
Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
